MedPath

The effects of oxytocin on trust and aggressio

Phase 2
Completed
Conditions
aggression
antisocial behavior
10034726
Registration Number
NL-OMON37316
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

males between the ages of 18 and 35 years, in good health, and able to understand the informed consent as assessed by the study physician.

Exclusion Criteria

No mental disorder, current or past history of drug or alcohol abuse or dependence, history of hypersensitivity to oxytocin, presence of or history of clinically significant allergic rhinitis, smoke more than 10 cigarettes per day. Subjects will be excluded when they cannot understand the Dutch language sufficiently to understand the purposes and implications of the experiment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Outcome measures will be:<br /><br>1) points scored on the PSAP (oxytocin vs placebo)<br /><br>2) points scored on the Trust Game (oxytocin vs placebo)<br /><br>3) salivary levels in testosterone and cortisol<br /><br>4) urinary and serum levels of oxytocin</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Outcome measures on the different questionnaires:<br /><br>1) Personality, as measured on the *Neuroticism-Extroversion-Openness<br /><br>Inventory- Five Factor Inventory* (NEO-FFI).<br /><br>2) traits of psychopathy, as measured on the *Triarchic - Psychopathy<br /><br>Measure* (TriPM).<br /><br>3) attachment styles, as measured on the *Relationship Questionnaire* (RQ) and<br /><br>the 'Experiences in Close Relationships' vragenlijst (ECR)<br /><br>4) trust, as measured on the *Trust Inventory* (TI)<br /><br>5) aggression as measuren on the agressie vragenlijst (AVL)<br /><br>6) Mood state, measured on 2 moments during the experiment, measured on the<br /><br>*Profile Of Mood States* (POMS). </p><br>
© Copyright 2025. All Rights Reserved by MedPath